China Digest: Xgene Pharmaceutical secures $40m; Biortus nets $30m

Photo: Getty Images Pro via DealStreetAsia

Chinese drug developer Xgene Pharmaceutical Group and Wuxi Biortus Biosciences have secured funding. 

Xgene Pharmaceutical secures $40m in Series C

Clinical-stage drug developer Xgene Pharmaceutical Group on Thursday announced that it has garnered $40 million in its Series C round of financing. 

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter